Dawn Chapelle

4.5k total citations
10 papers, 200 citations indexed

About

Dawn Chapelle is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dawn Chapelle has authored 10 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dawn Chapelle's work include Inflammasome and immune disorders (9 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Neonatal Respiratory Health Research (2 papers). Dawn Chapelle is often cited by papers focused on Inflammasome and immune disorders (9 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Neonatal Respiratory Health Research (2 papers). Dawn Chapelle collaborates with scholars based in United States, Canada and Switzerland. Dawn Chapelle's co-authors include Raphaela Goldbach‐Mansky, Adriana A. de Jesus, Deborah L. Stone, Raphaela Goldbach‐Mansky, Nicole Plass, Pamela Stratton, Daniel L. Kastner, Cailin H. Sibley, Catherine Y. Spong and Zenas Chang and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology and JCI Insight.

In The Last Decade

Dawn Chapelle

10 papers receiving 192 citations

Peers

Dawn Chapelle

IMMUN

HEMAT

PHEOH

RHEUM

Nicole Plass United States

Elisabeth Weißbarth‐Riedel Germany

S. Rouaghe France

Torbjörn Kullenberg Sweden

Virginia Messia Italy

Olga Feld Israel

Leonardo Oliveira Mendonça Brazil

Niran J. Amar United States

Ayako Tsuchiya‐Suzuki Japan

Reza Shiari Iran

Nicole Plass United States

Dawn Chapelle

104 ×0.9

70 ×0.8

IMMUN

39 ×0.5

HEMAT

44 ×1.0

PHEOH

33 ×0.8

RHEUM

Citations per year, relative to Dawn Chapelle Dawn Chapelle (= 1×) peers Nicole Plass

Countries citing papers authored by Dawn Chapelle

Since Specialization

Citations

This map shows the geographic impact of Dawn Chapelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Chapelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Chapelle more than expected).

Fields of papers citing papers by Dawn Chapelle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Chapelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Chapelle. The network helps show where Dawn Chapelle may publish in the future.

Co-authorship network of co-authors of Dawn Chapelle

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Chapelle. A scholar is included among the top collaborators of Dawn Chapelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Chapelle. Dawn Chapelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Jesus, Adriana A. de, Dawn Chapelle, Paul Dancey, et al.. (2017). Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist. JCI Insight. 2(16). 35 indexed citations

Rodriguez‐Smith, Jackeline, Wanxia Li Tsai, Hanna Kim, et al.. (2017). Cerebrospinal Fluid Cytokines Correlate With Aseptic Meningitis and Blood–Brain Barrier Function in Neonatal‐Onset Multisystem Inflammatory Disease: Central Nervous System Biomarkers in Neonatal‐Onset Multisystem Inflammatory Disease Correlate With Central Nervous System Inflammation. Arthritis & Rheumatology. 69(6). 1325–1336. 33 indexed citations

Malle, Louise, et al.. (2015). Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN. Pediatric Rheumatology. 13(S1). 7 indexed citations

Sibley, Cailin H., Laurence Colin, Abhijit Chakraborty, et al.. (2014). A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease. Annals of the Rheumatic Diseases. 74(9). 1714–1719. 44 indexed citations

Chang, Zenas, Catherine Y. Spong, Adriana A. de Jesus, et al.. (2014). Brief Report: Anakinra Use During Pregnancy in Patients With Cryopyrin‐Associated Periodic Syndromes. Arthritis & Rheumatology. 66(11). 3227–3232. 65 indexed citations

Rodriguez‐Smith, Jackeline, Yen-Chih Lin, Hanna Kim, et al.. (2014). A173: Cerebrospinal Fluid Cytokines Correlate With Innate Immune Cells in Neonatal Onset Multisystem Inflammatory Disease (NOMID) Patients in Clinical Remission Treated With Anakinra. Arthritis & Rheumatology. 66(S3). 4 indexed citations

Jesus, Adriana A. de, Gina Montealegre, Yin Liu, et al.. (2014). A de novo nonsense mutation in the tyrosine kinase lyn in a patient with an early onset autoinflammatory phenotype. Pediatric Rheumatology. 12(S1). 5 indexed citations

Canna, Scott, Adriana A. de Jesus, Zuoming Deng, et al.. (2014). A157: Macrophage Activation Syndrome‐like Illness Due to an Activating Mutation in NLRC4. Arthritis & Rheumatology. 66(S3). 4 indexed citations

Olivecrona, H., Karin Söderberg, B. Hallén, et al.. (2013). OP0061 Kineret® (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data. Annals of the Rheumatic Diseases. 72. A70–A71. 2 indexed citations

10.

Leinonen, M., Karin Söderberg, H. Olivecrona, et al.. (2013). SAT0440 The IL-1RA Antagonist Kineret® (Anakinra) Stabilizes Hearing Loss in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS). Annals of the Rheumatic Diseases. 72. A730–A731. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact